TRIMTECH Therapeutics raises $44.1M Seed (United Kingdom, Jun 2026)
$44.1M
€41 millionGenerated social card
Headline
Cambridge’s TRIMTECH Therapeutics brings Seed round to €41 million for neurodegenerative disease work - EU-Startups
About
TRIMTECH Therapeutics is focused on developing innovative treatments for neurodegenerative diseases. The company aims to address significant unmet medical needs in this area, making it a notable player in the health sector. The recent funding round will support their research and development efforts.
Article summary
Cambridge’s TRIMTECH Therapeutics brings Seed round to €41 million for neurodegenerative disease work EU-Startups
Investors
Related rounds
| Jul 13, 2026 | HBD | $130.0M | Grant | United Kingdom |
| Jul 13, 2026 | Reformed | $22.0M | Series A | United Kingdom |
| Jul 13, 2026 | Henry Boot | $130.0M | Grant | United Kingdom |
| Jul 10, 2026 | Luffy AI | $10K | Series A | United Kingdom |